Normally when you put out a product, you want to take sales away from the competition, not from other products that you sell yourself. But that's exactly what Gilead Sciences (NASDAQ:GILD) is doing, and Motley Fool health care analyst David Williamson thinks it's a great move.  Watch the video to find out why.